W. G. Zhang

发表

Involvement of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells.

B. Zhang, S. Luo, J. Guan, 2005, Journal of experimental & clinical cancer research : CR.

Serological identification and bioinformatics analysis of immunogenic antigens in multiple myeloma

W. Zhao, G. Chen, W. G. Zhang, 2006, Cancer Immunology, Immunotherapy.

Expression and mutation of the tumor suppressor gene p53 in AIDS-associated Kaposi's sarcoma.

C. Cockerell, J. J. Li, A. Friedman-kien, 1997, The American Journal of dermatopathology.

HPV-16-related DNA sequences in Kaposi's sarcoma

E. Coutavas, M. Rush, J. J. Li, 1992, The Lancet.

Expression of int-2 oncogene in Kaposi's sarcoma lesions.

J. J. Li, D. Moscatelli, C. Basilico, 1993, The Journal of clinical investigation.

The absence of Tat sequences in tissues of HIV‐negative patients with epidemic Kaposi's sarcoma

J. J. Li, A. Buchbinder, A. Friedman-kien, 1992, AIDS.

Proteosomal degradation of naturally recurring R260C missense and exon‐IV deletion mutants of factor XIII A‐subunit expressed in mammalian cells

A. Ichinose, W. G. Zhang, M. Souri, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer.

P. Frost, J. Skotnicki, C. Discafani, 2001, Endocrine-related cancer.

Transcription of human herpesvirus-like agent (HHV-8) in Kaposi's sarcoma.

J. J. Li, A. Friedman-kien, W. G. Zhang, 1996, The Journal of clinical investigation.

Gene amplification and multiple mutations of the K-ras oncogene in Kaposi's sarcoma.

J. J. Li, A. Friedman-kien, W. G. Zhang, 1994, Anticancer research.

Increased expression of fibroblast growth factors (FGFs) and their receptor by protamine and suramin on Kaposi's sarcoma-derived cells.

J. J. Li, A. Friedman-kien, W. G. Zhang, 1993, Anticancer Research.